Table 2.

Effect of acute Δ9-THC treatment on basal and WIN 55212-2-stimulated [35S]GTPγS binding in the rat brain

RegionBasalStimulated
ControlAcute Δ9-THCControlAcute Δ9-THC
Hippocampus (D)100  ± 4%92  ± 2%161  ± 12%140  ± 6%
Hippocampus (M)100  ± 5%116  ± 5%172  ± 24%176  ± 5%
Hippocampus (V)100  ± 14%123  ± 2%183  ± 13%194  ± 8%
Perirhinal cortex (M)100  ± 5%112  ± 6%161  ± 17%166  ± 8%
Perirhinal cortex (V)100  ± 1%101  ± 3%145  ± 5%147  ± 8%
Entorhinal cortex (D)100  ± 6%97  ± 1%155  ± 10%148  ± 4%
Entorhinal cortex (M)100  ± 7%120  ± 6%170  ± 12%176  ± 6%
Entorhinal cortex (V)100  ± 16%112  ± 4%157  ± 10%164  ± 7%
Septum100  ± 7%97  ± 10%141  ± 6%127  ± 5%
Caudate-putamen (D)100  ± 10%100  ± 3%190  ± 19%181  ± 2%
Caudate-putamen (M)100  ± 10%112  ± 2%183  ± 11%201  ± 4%
Globus pallidus100  ± 7%109  ± 6%382  ± 23%379  ± 10%
Substantia nigra100  ± 8%116  ± 1%393  ± 21%437  ± 12%
Cerebellum100  ± 6%115  ± 5%194  ± 21%189  ± 6%
PAG100  ± 6%102  ± 7%122  ± 6%124  ± 5%
  • Sections were incubated with 2 mm GDP, and then with [35S]GTPγS (0.04 nm) and 2 mmGDP, in the presence and absence of 10 μm WIN 55212-2. Data are expressed as percentage of control basal binding and represent mean values ± SE of duplicate sections from three animals. The level of the sections measured are dorsal (D), midlevel (M), and ventral (V).